REAL WORLD EXPERIENCE WITH DOLUTEGRAVIR-BASED TWO-DRUG REGIMENS

被引：0
|
作者：
Garris, C. [1 ]
Dhir, S. [1 ]
Waller, J. [2 ]
Roberts, J. [2 ]
Mycock, K. [2 ]
Oglesby, A. [1 ]
Collins, B. [1 ]
Dominguez, M. [1 ]
Pike, J. [2 ]
Mrus, J. M. [1 ]
机构：
[1] ViiV Healthcare, Res Triangle Pk, NC USA
[2] Adelphi Real World, Bollington, England
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
10.1016/j.jval.2019.04.879
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PIN5
引用
收藏
页码：S195 / S195
页数：1
相关论文
共 50 条
  • [1] Real-World Experience with Dolutegravir-Based Two-Drug Regimens
    Ward, Douglas
    Ramgopal, Moti
    Riedel, David J.
    Garris, Cindy
    Dhir, Shelly
    Waller, John
    Roberts, Jenna
    Mycock, Katie
    Oglesby, Alan
    Collins, Bonnie
    Dominguez, Megan
    Pike, James
    Mrus, Joseph
    AIDS RESEARCH AND TREATMENT, 2020, 2020
  • [2] Effectiveness and safety of dolutegravir-based two-drug regimens in a multicentre cohort in Spain
    Alejos, B.
    Suarez-Garcia, I.
    Martin-Carbonero, L.
    Moreno-Zamora, A.
    Font, R.
    Portilla, J.
    Martinez, O.
    Omar, M.
    Vinuesa, D.
    Moreno Guillen, S.
    Jarrin, I.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2022, 25 : 91 - 92
  • [3] Performance of dolutegravir-based two-drug regimens (DTG-2DR) in a large real-world cohort of people with HIV
    Bowman, Conor
    Ambrose, Alissa
    Simoes, Pedro
    Florman, Katia
    Kanitkar, Tanmay
    Katiyar, Abhishek
    Hunter, Alan
    Hart, Jennifer
    Barber, Tristan
    HIV MEDICINE, 2022, 23 : 24 - 24
  • [4] Performance of dolutegravir-based two-drug regimens (DTG-2DR) in a large real-world cohort of people with HIV
    Bowman, C.
    Ambrose, A.
    Simoes, P.
    Florman, K.
    Kanitkar, T.
    Katiyar, A.
    Hunter, A.
    Hart, J.
    Barber, T.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2022, 25 : 94 - 95
  • [5] Switching to dolutegravir-based two-drug regimens (DTG-2DR): performance in clinical practice
    Hart, J.
    Katiyar, A.
    Smith, C.
    Hunter, A.
    Burns, F.
    Youle, M.
    Barber, T. J.
    HIV MEDICINE, 2020, 21 : 21 - 22
  • [6] Real world use of dolutegravir two drug regimens
    Bowman, Conor
    Ambrose, Alissa
    Kanitkar, Tanmay
    Flores, Katia
    Simoes, Pedro
    Hart, Jennifer
    Hunter, Alan
    Akodu, Jane
    Barber, Tristan J.
    AIDS, 2023, 37 (05) : 785 - 788
  • [7] A comparison between two dolutegravir-based two-drug regimens as switch strategies in a multicentre cohort of HIV-1-infected patients
    Ciccullo, Arturo
    Baldin, Gianmaria
    Capetti, Amedeo
    Rusconi, Stefano
    Sterrantino, Gaetana
    d'Ettorre, Gabriella
    Colafigli, Manuela
    Modica, Sara
    Lagi, Filippo
    Giacomelli, Andrea
    Cossu, Maria Vittoria
    Restelli, Sibilla
    De Luca, Andrea
    Di Giambenedetto, Simona
    ANTIVIRAL THERAPY, 2019, 24 (01) : 63 - 67
  • [8] Real-world experience with the two-drug regimen dolutegravir and lamivudine in women with HIV: a systematic literature review
    di Giambenedetto, S.
    Walmsley, S.
    Grinsztejn, B.
    Perez-Elias, M.
    Nwokolo, N.
    Kabra, M.
    Jones, B.
    Letang, E.
    Kisare, M.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2022, 25 : 51 - 52
  • [9] Two-Drug Regimens Dolutegravir/Lamivudine and Dolutegravir/Rilpivirine Are Effective with Few Discontinuations in US Real-World Settings: Results from the TANDEM Study
    Schneider, Stefan
    Blick, Gary
    Burke, Christina
    Ward, Douglas
    Benson, Paul
    Felizarta, Franco
    Green, Dallas
    Donovan, Cynthia
    Harper, Gavin
    Merrill, Deanna
    Metzner, Aimee A.
    Mycock, Katie
    Wallis, Hannah
    Patarroyo, Jimena
    Brogan, Andrew P.
    Oglesby, Alan
    INFECTIOUS DISEASES AND THERAPY, 2024, 13 (04) : 891 - 906
  • [10] Two-Drug Regimens Dolutegravir/Lamivudine and Dolutegravir/Rilpivirine Are Effective with Few Discontinuations in US Real-World Settings: Results from the TANDEM Study
    Stefan Schneider
    Gary Blick
    Christina Burke
    Douglas Ward
    Paul Benson
    Franco Felizarta
    Dallas Green
    Cynthia Donovan
    Gavin Harper
    Deanna Merrill
    Aimee A. Metzner
    Katie Mycock
    Hannah Wallis
    Jimena Patarroyo
    Andrew P. Brogan
    Alan Oglesby
    Infectious Diseases and Therapy, 2024, 13 : 891 - 906
12345